Foghorn Therapeutics (FHTX) Revenue Growth (1y) (2021 - 2026)
Foghorn Therapeutics (FHTX) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Foghorn Therapeutics |
282.33 Mn |
193.42 Mn |
- |
-45.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
-45.11% |
| Dec 31, 2025 |
223.77% |
| Sep 30, 2025 |
4.42% |
| Jun 30, 2025 |
9.71% |
| Mar 31, 2025 |
17.86% |
| Dec 31, 2024 |
-50.49% |
| Sep 30, 2024 |
-55.33% |
| Jun 30, 2024 |
23.02% |
| Mar 31, 2024 |
-4.88% |
| Dec 31, 2023 |
37.88% |
| Sep 30, 2023 |
163.46% |
| Jun 30, 2023 |
24.70% |
| Mar 31, 2023 |
35.43% |
| Dec 31, 2022 |
486.82% |
| Sep 30, 2022 |
16,080.49% |
| Jun 30, 2022 |
1,509.32% |
| Mar 31, 2022 |
1,270.63% |
| Dec 31, 2021 |
184.06% |
| Sep 30, 2021 |
-77.09% |
